Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.
Press releases published on April 10, 2025

BriaCell's Subsidiary, BriaPro, Develops Novel Antibodies to Anti-Cancer Target B7-H3
BriaPro is developing novel antibodies to B7-H3, a key cancer antigen and immune checkpoint Highly expressed on the cell surfaces of both tumor and immune cells, B7-H3 is a promising anti-cancer target for drugs both effecting cancer cells and blocking …

NevGold Discovers More Significant Oxide Gold-Antimony Results: 1.70 g/t AuEq Over 169.2 Meters (0.89 g/t Au And 0.18% Antimony), Including 2.85 g/t AuEq Over 54.4 Meters (2.26 g/t Au And 0.13% Antimony), and Also Including 13.15 g/t AuEq Over 3.1…
Vancouver, British Columbia, April 10, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has discovered further significant oxide gold-antimony (“Antimony”, “Sb”) …

Adlai Nortye to Present Research Findings at AACR Annual Meeting 2025
SINGAPORE and NORTH BRUNSWICK, N.J. and HANGZHOU, China, April 10, 2025 (GLOBE NEWSWIRE) -- Adlai Nortye Ltd. (NASDAQ: ANL) (the “Company” or “Adlai Nortye”), a clinical-stage biotechnology company focused on the development of innovative cancer therapies, …

Zscaler ThreatLabz 2025 VPN Risk Report: Over Half of Organizations Say Security and Compliance Risks Make VPNs Obsolete
Key Findings: 92% of organizations are concerned about ransomware attacks due to VPN vulnerabilities 93% of organizations fear backdoor vulnerabilities from third-party VPN connections 81% of organizations are adopting or planning to adopt zero trust …

American Rebel CEO Andy Ross Appears on Miami TV WSFL – Home of the Florida Panthers and is Featured in the New York Post for his Meetings at Mar-A-Lago as the Brand Continues to Expand its Footprint in Florida
Miami Television Appearance and Investor Meetings at Mar-a-Lago Signal Big Moves for the Nation’s Fast-Growing Beer Brand – American Rebel Light Beer Nashville, TN, April 10, 2025 (GLOBE NEWSWIRE) -- American Rebel Holdings, Inc. (NASDAQ: AREB) ("American …

RedCloud Launches Red101 Agentic AI and new actionable market insights, advancing supply chain accessibility for global and local trade
LONDON, April 10, 2025 (GLOBE NEWSWIRE) -- Trading platform company RedCloud Holdings plc ("RedCloud" or the "Company") has announced the launch of its innovative Red101 agentic AI technology providing intuitive trading intelligence to its platform in fast …

Ace Vision Group to Host “Take the Presbyopia Challenge” Event and Present Scientific Posters at 2025 ASCRS Annual Meeting
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Ace Vision Group, Inc. (“AVG” or “the Company”), an emerging medical device company on the forefront of pioneering a laser microporation therapy for the aging eye, today announced that it will host an event and …

ZenaTech Closes Miller Land Surveying Corporation, a Third Southeast Acquisition and a Fourth Nationally for the Drone as Service (DaaS) Rollout
VANCOUVER, British Columbia, April 10, 2025 (GLOBE NEWSWIRE) -- ZenaTech, Inc. (Nasdaq: ZENA) (FSE: 49Q) (BMV: ZENA) ("ZenaTech"), a technology company specializing in AI (Artificial Intelligence) drone, Drone-as-a-Service (DaaS), enterprise SaaS and …

Alterity Therapeutics Presents Encouraging New Data from its ATH434 Phase 2 Trial in Multiple System Atrophy at the American Academy of Neurology Annual Meeting
– Clinically Meaningful Efficacy Observed on Multiple Assessments – – Confirmed Target Engagement with Reduced Iron Signal in MSA Affected Brain Regions – MELBOURNE, Australia and SAN FRANCISCO, April 10, 2025 (GLOBE NEWSWIRE) -- Alterity Therapeutics (ASX …

Paratek Pharmaceuticals to Present New Data on NUZYRA® (omadacycline) at ESCMID Global 2025
BOSTON, April 10, 2025 (GLOBE NEWSWIRE) -- Paratek Pharmaceuticals, Inc., a privately held pharmaceutical company developing specialty therapies for community care and public health challenges, today announced that data from several new studies of NUZYRA® …

HPQ Silicon and Novacium Sign MOU with GLD Alloys to produce Green Hydrogen with METAGENE™
MONTREAL and LYON France, April 10, 2025 (GLOBE NEWSWIRE) -- HPQ Silicon Inc. (“HPQ” or the “Company”) (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), a technology company specializing in green engineering processes, along with its French subsidiary NOVACIUM SAS (“ …

HPQ Silicium et Novacium signent un protocole d’entente (MOU) avec GLD Alloys pour produire de l’hydrogène vert avec METAGENE™
MONTRÉAL et LYON, France, 10 avr. 2025 (GLOBE NEWSWIRE) -- HPQ Silicium inc. (« HPQ » ou « la Société ») (TSX-V: HPQ, OTCQB: HPQFF, FRA: O08), une entreprise technologique spécialisée dans l’ingénierie verte des procédés, et sa filiales française NOVACIUM …

Quoin Pharmaceuticals Releases Second Episode of its “Living with Netherton” Series, as part of its ongoing NETHERTON NOW awareness campaign
Episode Highlights a Truly Remarkable Patient Story Spanning 79 Years Video features 79-year-old Norma Coles, believed to be among the earliest individuals ever evaluated for Netherton Syndrome and is available on the company’s NETHERTON NOW website …

TG Therapeutics Announces Data Presentations for BRIUMVI in Multiple Sclerosis at the American Academy of Neurology 2025 Annual Meeting
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ: TGTX), announced the presentation of data yesterday highlighting BRIUMVI® (ublituximab-xiiy) in patients with relapsing forms of multiple sclerosis (RMS), at the American Academy …

Draganfly and SafeLane Global Enter into Multi-Year Agreement with Draganfly as the Preferred Global Provider of Landmine Mapping Drones and Aerial Survey Services
First Ukraine Landmine Aerial Survey Contract Underway Tampa, FL, April 10, 2025 (GLOBE NEWSWIRE) -- Draganfly Inc. (NASDAQ: DPRO) (CSE: DPRO) (FSE: 3U8) (“Draganfly” or the “Company”), an industry-leading developer of drone solutions and systems, today …

Pasithea Therapeutics Announces Positive Safety Review Committee (SRC) Recommendation from its Ongoing Phase 1 Clinical Trial of PAS-004 in Advanced Cancer
– SRC recommended that the trial escalate to the next dose level of 30mg capsule – – No dose-limiting toxicities (DLT’s) or rash observed to date – MIAMI, April 10, 2025 (GLOBE NEWSWIRE) -- Pasithea Therapeutics Corp. (NASDAQ: KTTA) (“Pasithea” or the “ …

AccuStem Sciences, Inc. Announces Chairman Purchase of Shares
LONDON and PHOENIX, April 10, 2025 (GLOBE NEWSWIRE) -- AccuStem Sciences, Inc. (OTCQB: ACUT), a clinical stage diagnostics company dedicated to improving outcomes for patients with cancer, announced that its Chairman of the Board, Mr. Gabriele Cerrone, has …

Axonius Federal Systems Achieves FedRAMP Moderate Authorization, Advances Cybersecurity Modernization Across U.S. Federal Agencies
RESTON, Va., April 10, 2025 (GLOBE NEWSWIRE) -- Axonius Federal Systems, the leader in cyber asset management that delivers visibility and actionability across all digital assets, announced that it has achieved Federal Risk and Authorization Management …

Eyenovia Provides Development Update on Optejet User Filled Device (UFD)
NEW YORK, April 10, 2025 (GLOBE NEWSWIRE) -- Eyenovia, Inc. (NASDAQ: EYEN) (“Eyenovia” or the “Company”), an ophthalmic technology company developing and commercializing advanced products leveraging its proprietary Optejet topical ophthalmic medication …

Climb Channel Solutions Announces Partnership with Thales
EATONTOWN, N.J., April 10, 2025 (GLOBE NEWSWIRE) -- Climb Channel Solutions, an international specialty technology distributor and wholly owned subsidiary of Climb Global Solutions, Inc. (NASDAQ: CLMB), announces a partnership with Thales, a global leader …